Hair Loss and Telogen Effluvium
This is the side effect that hits differently. Nausea, fatigue, GI issues — those are uncomfortable, but they feel temporary and manageable. Finding clumps of hair in your shower drain or noticing your ponytail getting thinner? That lands in a more personal place. It touches how you see yourself, and it can feel like your body is falling apart even when everything else about your health is improving.
So let’s start with the most important thing: hair loss on GLP-1 medications is uncommon, temporary, and — in every clinical trial that’s tracked it — fully reversible. Not one person discontinued their medication because of it. Your hair grows back.
That doesn’t make it less stressful in the moment. But understanding what’s actually happening, why it happens, and how long it lasts can take a lot of the panic out of it. Because the panic is usually worse than the reality.
How Common Is It?
Less common than the internet would have you believe.
Semaglutide (Wegovy): 3% experienced hair loss in clinical trials, compared to 1% on placebo. Among people who lost more than 20% of their body weight, the rate went up to 5.3% — versus 2.5% in those who lost less. Notably, Ozempic (the lower-dose version prescribed for diabetes) doesn’t even list hair loss as a common side effect.[1]
Tirzepatide (Zepbound): 4.9-5.7% depending on the dose, compared to 0.9% on placebo. Women were significantly more affected — 7.1% versus 0.5% of men. Zero people stopped taking the medication because of hair loss. And the FDA label says the quiet part out loud: hair loss is “associated with weight reduction” — not the drug itself.[2][3]
For context: after bariatric surgery — which causes faster, more dramatic weight loss — hair loss rates are 47-57%. GLP-1 rates of 3-6% are dramatically lower by comparison.[4]
A large pharmacovigilance study using data from over 100 million patients found that GLP-1 use was associated with a modest increase in hair loss reports — but the increase tracked with the degree of weight loss, reinforcing that it’s the weight change driving this, not a direct drug effect.[5]
The math in your favor: 94-97% of people in clinical trials experienced no hair loss at all.
What's Actually Happening: The Hair Cycle
To understand why this happens, you need to know a little about how hair grows. It’s not as complicated as it sounds, and it explains almost everything about the timing and pattern of hair loss on GLP-1 medications.
Your hair follicles cycle through three phases:
Anagen (growth phase): This is where about 85% of your hair is at any given time. Each hair actively grows for 3-4 years. This phase is metabolically expensive — your body is building keratin (the protein hair is made of) and supplying blood and nutrients to every follicle.
Catagen (transition phase): A brief 2-3 week phase where the follicle shrinks and detaches from its blood supply. Think of it as the follicle powering down.
Telogen (resting phase): About 15% of your hair is normally in this phase, resting for 3-4 months. At the end of telogen, the hair falls out as a new hair starts growing underneath it. Losing 50-100 hairs a day from this process is completely normal.
What Goes Wrong
When your body experiences a significant stress — rapid weight loss, major caloric restriction, nutritional deficiency, surgery, illness, even severe emotional stress — it does something that makes biological sense but feels alarming: it triages. Hair isn’t essential for survival, so your body diverts resources away from hair growth and toward more critical functions.
What happens is that a large percentage of your growing hairs — potentially up to 70% — get pushed prematurely from the anagen (growth) phase into telogen (resting). They don’t fall out immediately. They sit in that resting phase for 3-4 months first. Then they shed.
This is why there’s a built-in delay. The weight loss happens in months 1-3. The hair loss shows up in months 3-6. By the time you notice hair in your drain, the trigger happened months ago — and in most cases, the trigger has already resolved.
This process has a name: telogen effluvium (TE). Your doctor or dermatologist might use this term. All it means is “a lot of resting hairs falling out at once because of a stressor.” It’s the most common form of non-genetic hair loss, and it happens after any significant physiological stress — not just GLP-1 medications.
Is It the Drug or the Weight Loss?
This is the question researchers have been working to answer, and the evidence points strongly in one direction: it’s the weight loss.
The case for weight loss being the primary driver is compelling:
- Hair loss rates track with the degree of weight loss, not the drug dose. People who lost more than 20% of their body weight had roughly double the rate of those who lost less.[1]
- The same phenomenon happens after bariatric surgery and crash dieting — at much higher rates.
- Ozempic (lower dose, less weight loss) doesn’t list it. Wegovy (higher dose, more weight loss) does.
- Zepbound’s FDA label explicitly states it’s “associated with weight reduction.”[3]
There are some open questions. GLP-1 receptors have been found on hair follicles in mice, though we don’t know what they do. And oddly, some case reports actually show hair regrowth in people on GLP-1 medications — the opposite of what you’d expect if the drug were directly toxic to follicles.[6]
The consensus among dermatologists and endocrinologists: weight-loss-mediated telogen effluvium is the primary driver. A minor direct drug effect can’t be completely ruled out, but it’s not what’s causing the vast majority of cases.[6][7]
The Timeline
Understanding the timeline takes a lot of the fear out of this, because every phase points toward recovery:
- Months 1–3: The silent phase — No visible changes. Internally, some follicles are shifting from growth to resting phase — but you can't see or feel it yet.
- Months 3–6: Shedding begins — Those follicles that shifted to resting phase 3–4 months ago are now releasing their hairs. This is when people notice more hair in the shower, on their pillow, or in their brush.
- Months 6–9: Peak, then slowing — The worst of it is usually over by month 9. New hairs are already starting to grow underneath.
- Months 9–12+: New growth visible — You'll notice shorter hairs coming in, especially around the hairline and part.
- Months 12–18: Full recovery — Full or near-full recovery for most people.
I didn’t experience significant hair loss personally, but I’ve talked to a lot of people who did — and the pattern is remarkably consistent. Months 3-5 are scary. You see hair coming out and your brain goes straight to worst-case scenarios. Then around month 7-8, it slows down. By month 12, most people are looking at their new growth and wondering what they were so worried about. The hardest part isn’t the hair loss itself — it’s the waiting. Knowing the timeline in advance is genuinely the most helpful thing, because it means you’re not sitting there wondering if it will stop. It will.
Why It Happens: The Mechanisms
Several factors work together to push hair follicles out of growth phase. Understanding them matters because several are preventable:
Caloric Restriction
Hair follicles are among the most metabolically active cells in your body. When caloric intake drops significantly — which it does on GLP-1 medications, often by 20-40% — your body redirects energy toward essential functions. Hair growth isn’t essential for survival, so it gets deprioritized. This is the same mechanism that causes hair loss during famine, eating disorders, or any form of severe caloric restriction.
Nutritional Deficiencies
Specific nutrients are critical for hair growth, and all of them become harder to get when you’re eating substantially less:
Protein — Hair is made of keratin, a protein. Inadequate intake directly impairs hair production
Iron — Essential for DNA synthesis in follicle cells. Low ferritin is one of the strongest predictors of telogen effluvium
Zinc — Involved in hair follicle cycling. A meta-analysis found deficiency was a significant predictor of hair loss[8]
Vitamin D — Deficiency independently triggers telogen effluvium — the most common deficiency on GLP-1 meds (13.6% at 12 months)[9]
Hormonal Shifts
Fat tissue produces estrogen through a process involving an enzyme called aromatase. When you lose a lot of fat, aromatase activity decreases, which can shift the testosterone-to-estrogen balance. In some people — particularly women — this shift can unmask an underlying tendency toward pattern hair loss (androgenetic alopecia) that was previously held in check by higher estrogen levels.
This is part of why a large population study found that GLP-1 use was associated with both telogen effluvium and androgenic alopecia — the rapid weight loss can trigger the temporary shedding and simultaneously reveal a separate, underlying pattern.[5]
Cortisol and Stress
Rapid weight loss elevates cortisol — your body’s primary stress hormone. Elevated cortisol triggers inflammatory signaling that can push follicles from the growth phase into resting phase. This is the same mechanism behind hair loss from emotional stress, illness, or surgery.
Who’s Most at Risk
Not everyone on a GLP-1 medication will experience hair loss. The strongest risk factors are:
Rate of weight loss — Losing more than 20% of body weight roughly doubles the risk[1]
Being female — Women are significantly more affected (7.1% vs 0.5% of men in the tirzepatide data)[2]
Pre-existing nutritional deficiencies — Especially iron, zinc, or vitamin D
History of hair loss — Previous telogen effluvium episodes or family history of pattern baldness
Inadequate protein intake — Eating too little protein while losing weight rapidly
What Actually Helps
The Foundation: Nutrition
Protein is non-negotiable. Aim for 1.2-1.6 grams per kilogram of body weight per day — practically, that’s roughly 70-100+ grams daily for most people. Your hair is made of protein. If you’re not eating enough, your body will deprioritize hair before it deprioritizes organs. This is the single most important intervention.
Iron: Only supplement if a blood test confirms you’re deficient. Low ferritin (below 30-40 ng/mL) is associated with hair loss and should be addressed. But iron supplementation when you’re not deficient isn’t helpful and can actually be harmful — excess iron is toxic. Get tested first.[8]
Zinc: A daily intake of 30mg has been recommended in post-bariatric and weight-loss contexts. Zinc deficiency is a significant predictor of hair loss, and it’s easy to become deficient when eating less.[8]
Vitamin D: Supplement if deficient — and get tested, because 13.6% of people on GLP-1 medications are deficient by 12 months. Vitamin D deficiency independently triggers telogen effluvium.[9]
Biotin: You’ll see this recommended everywhere. The evidence is weak — biotin supplementation doesn’t help unless you have a true biotin deficiency, which is rare. More importantly, biotin supplements can interfere with thyroid lab tests, potentially causing false readings. Low risk, but also low evidence of benefit.[8]
Minoxidil (If Needed)
If hair loss is significant and bothersome, topical minoxidil (the active ingredient in Rogaine) is an option worth discussing with your provider or dermatologist. A 2025 clinical trial showed approximately 70% improvement at 24 weeks in patients with weight-loss-related hair thinning.[10]
Minoxidil doesn’t stop the telogen shedding — that resolves on its own. What it does is stimulate new growth and may speed up the recovery timeline. It’s available over the counter in 2% and 5% formulations.
What NOT to Do
Most are overpriced combinations of biotin and herbs with no clinical evidence for telogen effluvium. Save your money.
Discuss it with your provider. The hair loss is temporary. The health benefits may be substantial. That's a conversation to have together, not a decision to make in the shower.
Both can actually worsen hair loss at high doses. More supplements aren't always better.
Seriously. Stress worsens cortisol, which worsens hair loss. The cycle is real.
When to See a Dermatologist
Most hair loss on GLP-1 medications is straightforward telogen effluvium that resolves on its own. But some patterns warrant a dermatology visit:
Rapidly worsening rather than following the typical gradual pattern.
By this point, telogen effluvium should be slowing. If it's not, something else may be going on.
Telogen effluvium is diffuse (all over), not patchy. Patches could indicate alopecia areata or another condition.
Fatigue, cold intolerance, unexpected weight changes, nail changes — these could suggest a thyroid issue or other underlying condition.
A dermatologist will typically check ferritin, zinc, selenium, thyroid panel, vitamin D, B12, and a complete blood count. In uncertain cases, a scalp biopsy can distinguish between different types of hair loss.
Telogen effluvium is classified as “benign and spontaneously reversible” in medical references. The word “benign” might feel dismissive when you’re watching your hair thin — but what it actually means is: your follicles aren’t damaged, your hair growth machinery is intact, and recovery is the expected outcome, not the exception. Source: StatPearls, 2024
The Bottom Line
Hair loss on GLP-1 medications is uncommon (3-6%), temporary, and driven by weight loss rather than the medication itself. It follows a predictable timeline — delayed onset at 3-6 months, peak shedding around months 6-9, and recovery by 12-18 months. Every clinical trial that tracked it reported full recovery. Not a single participant stopped treatment because of it.
The best things you can do: eat enough protein, make sure you’re not deficient in iron, zinc, or vitamin D, and — perhaps most importantly — know what to expect. Hair loss is alarming precisely because most people don’t see it coming. Now you know the timeline. If it happens to you, you’ll recognize it for what it is: a temporary, manageable consequence of your body adjusting to significant change. Not a sign of damage. Not permanent. Just your body triaging while it figures out its new normal.
Your hair will figure it out too. Give it time.
Sources:
- Novo Nordisk. “Wegovy (semaglutide) Prescribing Information.” FDA, 2025.
- Jastreboff AM et al. “Tirzepatide for Obesity — SURMOUNT-1.” New England Journal of Medicine, 2022.
- Eli Lilly. “Zepbound (tirzepatide) Prescribing Information.” 2024.
- Kermansaravi M et al. “Hair Loss After Bariatric Surgery.” Obesity Surgery, 2021.
- George Washington University. “Study Links GLP-1 Weight Loss Drugs to Increased Risk of Hair Loss.” 2025.
- Buontempo MG et al. “GLP-1 Receptor Agonists and Hair Loss.” Journal of the European Academy of Dermatology and Venereology, 2025.
- Alsuwailem A et al. “Hair Loss and GLP-1 Receptor Agonists — Review.” Cureus, 2025.
- National Center for Biotechnology Information. “Telogen Effluvium.” StatPearls, 2024.
- “Nutritional Deficiencies Among GLP-1 Receptor Agonist Users.” PMC, 2025.
- “Minoxidil for Weight-Loss-Related Hair Thinning.” PMC, 2025.
Want to Start Tracking Your Progress?
Printable templates designed for people on GLP-1 medications — side effect trackers, progress logs, meal planners, and more.
View Templates